Ilika plc award share options under the long term incentive plan

Ilika plc

Ilika plc (LON:IKA), a pioneer in solid-state battery technology, has announced that on 7 February 2022 it granted nominal value options over 229,759 ordinary shares of 1p each in the Company to Executive Directors under the Long Term Incentive Plan 2018. Each award vests on the achievement of certain performance targets over a three-year period. The options granted represent in aggregate 0.15 per cent of the Company’s issued share capital.

In addition, on 7 February 2022, 20,000 nominal value options previously awarded under the Company’s bonus scheme have been exercised by Steve Boydell, CFO, and the Executive Directors sold 30,000 shares in aggregate, primarily to cover tax liabilities arising from options exercised under the Company’s bonus scheme in 2021 and 2022.

Details of grants issued under the Company’s Long Term Incentive Plan 2018, options exercised and Ordinary Shares sold by each Executive Director are set out in the tables below, together with the total number of Ordinary Shares each Executive Director holds under option and is interested in.

DirectorNumber of options grantedNumber of options exercisedTotal number of Options now heldPer cent. of issued share capital
Graeme Purdy153,541–2,362,1131.50
Steve Boydell76,21820,000755,7230.48
DirectorOrdinary shares soldNumber of shares held post salePer cent. of issued share capital
Graeme Purdy15,000782,9270.50
Steve Boydell15,00058,3460.04

EMI option scheme

Following the vesting of options under Ilika’s EMI share option schemes, 52,500 options with an exercise price of 21p, together with 265,000 options with an exercise price of 18.2p, have been converted into Ordinary shares of 1p each. 

Accordingly, to satisfy options exercised under both the Company’s EMI share option schemes and bonus scheme, the Company has applied to the London Stock Exchange for 337,500 Ordinary Shares to be admitted to trading on AIM. It is expected that Admission will occur at 8.00am on 11 February 2022.

Total Voting Rights

Following Admission, the Ilika issued share capital will comprise 157,217,043 Ordinary Shares and may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA’s Disclosure Guidance and Transparency Rules. The Company does not hold any shares in treasury. 

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika plc: ORKA Launch Opens New Commercial Opportunities for Goliath in Marine and Defence Markets (video)

Ilika CEO Graeme Purdy explains how ORKA could accelerate Goliath's commercialisation through underwater defence applications while maintaining the company's long-term electric vehicle strategy.

Ilika launches ORKA brand as it targets deep-sea battery demand

Ilika has launched ORKA for pressure-tolerant deep-sea batteries aimed at autonomous underwater vehicles and defence applications.

Ilika launches ORKA brand for deep-sea battery systems

ika has launched ORKA, a new brand for its pressure-tolerant batteries designed for autonomous underwater vehicles. The technology supports operations at depths of up to 6,000 metres and forms part of the company's strategy to commercialise its Goliath batteries in defence and other non-automotive markets.

Ilika to attend NANS 2027 in Las Vegas

Ilika will attend NANS 2027 in Las Vegas, engaging with the neuromodulation and medical technology sectors as it develops its Stereax solid-state batteries for medical devices.

Ilika targets earlier commercialisation opportunities for Goliath solid-state batteries

Ilika is pursuing defence and e-bike applications to accelerate commercial opportunities for its Goliath solid-state batteries while continuing development for the electric vehicle market.

Ilika’s Stereax batteries to be represented at MD&M Midwest 2026

Ilika's Stereax miniature solid-state batteries will be represented by Cirtec Medical at MD&M Midwest in Minneapolis as the company continues to develop medical device applications.

Search